Breaking News

Aptar CSP Awarded $19M U.S. Govt. Contract for Activ-Film Technology

To support expanded domestic production capacity for Activ-Film technology used to protect and ensure COVID-19 test kit integrity and accuracy.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aptar CSP Technologies has been awarded a $19 million contract from the U.S. government to support expanded domestic production capacity for the company’s Activ-Film technology, which is used to protect and ensure COVID-19 test kit integrity and accuracy.   Aptar CSP’s Activ-Film technology is seamlessly integrated into diagnostic dipsticks and lateral flow cassettes to protect diagnostic tests from moisture or other environmental degradants that can impact test integrity and result accuracy. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters